Haemonetics' GAAP net income for 9 months of fiscal year 2022 was $33.634 million, down 2.7 times from $90.51 million in the prior year. Revenue increased 12.8% to $728.194 million from $645.434 million a year earlier.
Haemonetics' GAAP net income for 9 months of fiscal year 2022 was $33.634 million, down 2.7 times from $90.51 million in the prior year. Revenue increased 12.8% to $728.194 million from $645.434 million a year earlier. 
English (US) 